The Korean Journal of Medicine

  • 제93권5호
  • /
  • Pages.447-451
  • /
  • 2018
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

새로운 고혈압 가이드라인에 따른 고혈압 진료

Evaluation and Management of Hypertensive Patients According to New Hypertension Guideline

  • 이해영 (서울대학교 의과대학 내과학교실)
  • Lee, Hae-Young (Department of Internal Medicine, Seoul National University College of Medicine)
  • 발행 : 2018.10.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021-3104. https://doi.org/10.1093/eurheartj/ehy339
  2. Conen D, Aeschbacher S, Thijs L, et al. Age-specific differences between conventional and ambulatory daytime blood pressure values. Hypertension 2014;64:1073-1079. https://doi.org/10.1161/HYPERTENSIONAHA.114.03957
  3. Johnson KC, Whelton PK, Cushman WC, et al. Blood pressure measurement in SPRINT (systolic blood pressure intervention trial). Hypertension 2018;71:848-857. https://doi.org/10.1161/HYPERTENSIONAHA.117.10479
  4. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991;18:67-71. https://doi.org/10.1161/01.HYP.18.1.67
  5. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898. https://doi.org/10.1056/NEJMoa0801369
  6. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008;31:2115-2127. https://doi.org/10.1291/hypres.31.2115
  7. SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-2116. https://doi.org/10.1056/NEJMoa1511939
  8. Hughes TM, Sink KM. Hypertension and its role in cognitive function: current evidence and challenges for the future. Am J Hypertens 2016;29:149-157. https://doi.org/10.1093/ajh/hpv180
  9. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
  10. Williams B, MacDonald TM, Morant S, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 2015;386:2059-2068. https://doi.org/10.1016/S0140-6736(15)00257-3
  11. Kim HC, Oh SM. Noncommunicable diseases: current status of major modifiable risk factors in Korea. J Prev Med Public Health 2013;46:165-172. https://doi.org/10.3961/jpmph.2013.46.4.165